medigraphic.com
ISSN 0188-9796 (Impreso)

2001, Número 3

<< Anterior Siguiente >>

Rev Endocrinol Nutr 2001; 9 (3)


Uso de anabólicos por atletas adolescentes

Barrientos PM

Idioma: Español
Referencias bibliográficas: 47
Paginas: 133-140
Archivo PDF: 181.01 Kb.


RESUMEN

El uso de fármacos anabólicos para favorecer el desempeño atlético se ha incrementando en forma importante, no sólo en atletas adultos sino también en adolescentes que se dedican a la práctica de un deporte. A continuación se realiza una revisión de los fármacos anabólicos más usados por los atletas, tanto anabólicos esteroideos como no esteroideos, se hace mención a los principales estudios publicados en los Estados Unidos de Norteamérica sobre el uso de anabólicos en adolescentes. Se detallan los efectos colaterales nocivos que pueden provocar, indicando la forma en que se administran y su supuesto mecanismo de acción. Por último, se concluye que es muy importante para los profesionales de la salud, dedicados a la atención del adolescente, conocer el tipo de medicamentos que se están utilizando y recomendar la suspensión de los mismos por los graves efectos colaterales que pueden provocar en detrimento de la salud de nuestros adolescentes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Metzl J. The Changing Role of the Pediatrician en: Pediatric Sports Medicine. Presentado en la 2000 Reunión Anual de la Academia Americana de Pediatría. Octubre 28-Noviembre 1, 2000; Chicago, Illinois.

  2. Wagner JC. Abuse of drugs used to enhance athletic performance Am J Hosp Pharm 1989; 46: 2059-67.

  3. Windsor RE, Dumitru D. Prevalence of anabolic steroid use by male and female adolescents. Med Sci Sports Exerc 1989; 21: 494-7.

  4. Faigenbaum AD, Zaichkowsky LD, Gardner DE, Micheli LJ. Anabolic Steroid Use by Male and Female Middle School Students. Pediatrics 1998; 101(5): e6.

  5. Haupt HA, Rovere GE. Anabolic steroids: a review of the literature. Am J Sports Med 1984; 12: 469-84.

  6. American Academy of Pediatrics, Committee on Sports Medicine. Anabolic steroids and the adolescent athlete. Pediatrics 1989; 83: 127-8.

  7. 7 American College of Sports Medicine. Position statement on the use and abuse of anabolic androgenic steroids in sports. Med Sci Sports Exerc 1977; 9: XI-XII.

  8. American College of Sports Medicine Position stand on anabolic-androgenic steroids. Med Sci Sports Exerc 1987; 19: 534-9.

  9. Committee on Sports Medicine and Fitness, American Academy of Pediatrics. Adolescents; and Anabolic Steroids: A Subject Review. Pediatrics 1997; 99(6): 904-8.

  10. Buckley WE, Yesalis CE, Friedl KE, Anderson WA, Streit AL, Wright JE. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988; 260: 3441-5.

  11. Johnson M, Jay S, Shoup B. Anabolic steroid use by male adolescents. Pediatrics 1989; 83: 921-24.

  12. Terney R, McLain L. The use of anabolic steroids in high school students. Am J Dis Child 1990; 144: 99-103.

  13. Tanner S, Miller D, Alongi C. Anabolic steroid use by adolescents: prevalence, motives and knowledge of risks. Clin J Sports Med 1995; 5: 108-15.

  14. DuRant P, Escobedo L, Heath G. Anabolic steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics 1995; 96: 23-8.

  15. Komoroski E, Rickert V. Adolescent body image and attitudes to anabolic steroid use. Am J Dis Child 1992; 146: 823-8.

  16. DuRant R, Ashworth C, Newman C. Stability of the relationships between anabolic steroid use and multiple substance use among adolescents. J Adolesc Health 1994; 15: 111-6.

  17. Barrientos-Pérez M. Uso de Anabólicos esteroideos en instructores de Fisicoconstructivismo. Archivo de la Federación Mexicana de Fisicoconstructivismo, A.C. 2001.

  18. Lamb DR. Anabolic steroids in athletics: how well do they work and how dangerous are they? Am J Sports Med 1984; 12: 31-8.

  19. Mayer M, Rosen F. Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol. Am J Physiol 1975; 229: 1381-6.

  20. Wilson JD. Androgen abuse by athletes. Endocr Rev 1988; 9: 181-99.

  21. Lund BC, Perry PJ. Androgenic Anabolic Steroids: An Overview for Clinicians. Medscape Pharmacotherapy, 2000.

  22. Perry PJ, Andersen KH, Yates WR. Illicit anabolic steroid use in athletes: a case series analysis. Am J Sports Med 1990; 18: 422-8.

  23. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 1987; 7: 230-6.

  24. Jarow JP, Lipshultz LI. Anabolic steroid-induced hypogonadotropic hypogonadism. Am J Sports Med 1990; 18: 429-31.

  25. Knuth UA, Maniera H, Nieschlag E. Anabolic steroids and semen parameters in bodybuilders. Fertil Steri 1989; 52: 1041-7.

  26. Turek PJ, Williams RH, Gilbaugh JH, Lipshultz LI. The reversibility of anabolic steroid-induced azoospermia. J Uro 1995; 153: 1628-30.

  27. Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels: a literature review. Arch Intern Med 1991; 151: 1925-33.

  28. Alen M, Rahkila P, Marniemi J. Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int J Sports Med 1985; 6: 139-44.

  29. Pope HG, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 1988; 45: 487-90.

  30. Su TP, Pagliaro M, Schmidt PJ, et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993; 269: 2760-4.

  31. Kouri EM, Lukas SE, Poper HG, et al. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend 1995; 40: 73-9.

  32. Landry GL, Primos WA Jr. Anabolic esteroid abuse. Adv Pediatr 1990; 37: 185-205.

  33. Graphery NA. Performance-enhancing drugs. Orthop Clin North Am 1995; 26: 433-42.

  34. Evans NA. Gym and tonic: a profile of 100 male steroid users. Br J Sports Med 1997; 31: 54-8.

  35. Sturmi JE, Diorio DJ. Anabolic agents. Clin Sports Med 1998; 17: 261-82.

  36. Yarasheski KE. Growth hormone effects on metabolism, body composition, muscle mass, and strength. Exerc Sport Sci Rev 1994; 22: 285-312.

  37. Frisch H. Growth hormone and body composition in athletes. J Endocrinol Invest 1999; 22: 106-9.

  38. Jones M, Pedoe DST. Blood doping: a literature review. Br J Sports Med 1989; 23: 84-8.

  39. Ekblom B, Berglund B. Effect of erythropoietin administration on maximal Aerobic power in man. Scand J Med Sci Sports 1991; 1: 125-30.

  40. Smith GM, Beecher HK Amphetamine, secobarbital, and athletic performance. II: Subjective evaluations of performances, mood states, and physical states. JAMA 1960; 172: 1502-14.

  41. King DS, Sharp RL, Vukovich MD. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA 1999; 281: 2020-8.

  42. Corrigan AB. Dehydroepiandrosterone and sport. Med J Aust 1999; 171: 206-8.

  43. Yen SS, Morales AJ, Khorram 0. Replacement of DHEA in aging men and women: potential remedial effects. Ann NY Acad Sci 1995; 774: 128-42.

  44. Anonymous. Creatine and androstenedione-two dietary supplements. Med Lett Drugs Ther 1998; 40: 105-6.

  45. Yesalis CE. Medical, legal, and societal implications of androstenedione use. JAMA 1999; 281: 2043-4.

  46. Terjung RL, Clarkson P, Eichner ER, et al. The physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc 2000; 32: 706-17.

  47. Rich JD, Dickinson BP, Merriman NA, Thule PM. Insulin use in bodybuilders. JAMA 1998; 279: 1613.




2020     |     www.medigraphic.com